about
Prevalence of microcephaly in Europe: population based studyAssociation between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)Symptomatic Management of Fever in Children: A National Survey of Healthcare Professionals' Practices in FranceEUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associationsSeasonality of congenital anomalies in Europe.The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe: An Ecological Time Series Study.Infant and toddler disease score was useful for risk of hospitalization based on data from administrative claims.Impact of preterm birth on infant mortality for newborns with congenital heart defects: The EPICARD population-based cohort studyRole of naloxone in newborn resuscitation.Human development index as a predictor of infant and maternal mortality rates.Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancyIndividual and organisational determinants associated with maintenance tocolysis in the management of preterm labour: a multilevel analysisHolt Oram syndrome: a registry-based study in Europe.Predictors of the risk of cognitive deficiency in very preterm infants: the EPIPAGE prospective cohort.Evaluating regional differences in breast-feeding in French maternity units: a multi-level approach.Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in EuropePopulation-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code.In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.Prevalence of esophageal atresia among 18 international birth defects surveillance programsA population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severityPaper 2: EUROCAT public health indicators for congenital anomalies in Europe.Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in EuropeEpidemiology of hypospadias in Europe: a registry-based study.Long term trends in prevalence of neural tube defects in Europe: population based studyTwenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.Meckel-Gruber Syndrome: a population-based study on prevalence, prenatal diagnosis, clinical features, and survival in EuropeAssessing sociodemographic differences (or lack thereof) in prenatal diagnosis of congenital heart defects: a population-based study.Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological consequences for women who undergo screening.New index of social deprivation during pregnancy: results from a national study in France.Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.Translating Neurodevelopmental Care Policies Into Practice: The Experience of Neonatal ICUs in France-The EPIPAGE-2 Cohort StudyDoes neonatal pain management in intensive care units differ between night and day? An observational study.Assessing the role of multiple pregnancies in the association between tetralogy of Fallot and assisted reproductive techniques: a path-analysis approach.Paper 6: EUROCAT member registries: organization and activities.Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study.Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors.Increased rate of spontaneous miscarriages in endometriosis-affected women.Use of hierarchical models to analyze European trends in congenital anomaly prevalence.National cross-sectional study of nonsteroidal anti-inflammatory drugs use highlights differences between parents and professionals and prompts safety concerns.
P50
Q26970768-C9537EE8-8F50-4883-A444-25B297D78655Q28538279-7CA7041F-83A2-440D-AADA-12AB114851BDQ28551138-A9721835-54C4-47E4-B19B-B6B707E4684FQ28817912-EF688673-A39B-45E3-B34C-C2DD430021EEQ30360301-F90D6C0B-102B-415F-8A9A-6C99110B9A1DQ30378633-4DE298D0-09F4-4AE6-B728-5C78923F0921Q31116021-06DC81B8-BC68-4ABB-9714-27397382361BQ33691652-1A5CB36E-4906-4116-A46B-DA8534FCD76AQ34051641-7141AFF6-7C1A-4111-9EF8-94502C58BF64Q34442160-16755754-5D40-4307-B56C-5770AE4F8F83Q34514946-57986CFE-528C-4D6C-AD42-63A59E3FEEA2Q34524997-0ACD7F56-021C-4B8F-A407-73750E144F6EQ34576306-BC418CBC-B9E1-484D-B660-37EB56F74739Q34830391-7ED9AAEB-72A3-4E89-B4EE-77C90B15F1A7Q34984297-C8B1C18C-AF30-4BF1-AD4F-997220876932Q35150515-F801DD89-2A70-4553-ADEB-6744097BAA6EQ35412867-DDE39308-92AC-4CFF-97F1-7CC803E0015CQ35594678-BC03F9E5-EBA0-4E39-B019-C192F3C77E97Q35741830-E45AE813-F4F0-46E5-9652-A875A67D54BCQ35846459-70A098C1-8431-460D-8E1C-1460B6C82839Q35870739-F3FA91ED-33E0-462E-A4BF-B740275D8579Q35874233-C93F622D-97A8-4D79-A1D5-90FDB6F9CD06Q35899367-4FA82873-2A6F-4D1B-9071-914426677D7BQ36304503-9B4415D5-D039-4498-9FD4-ADA5522F1AF9Q36316162-98CE2CEB-E9E8-45D1-82D8-62274A960616Q36466446-AA0EB8FE-E887-424F-B513-2EF0913CCD1BQ36695145-6AADC869-49B3-467E-846F-283D3CA69437Q36732829-E86DE695-98B1-4DB5-9F92-4B71780A876BQ36767678-EFCCD487-986E-45FC-80CD-72F9E2E4F8C1Q36773317-43942948-363D-4EF2-895A-E92106B7DC0BQ36862763-27786425-0DC0-47B2-B30E-853D9A5A813DQ37309619-64741A1C-842E-4F36-861E-2B5D209D04ECQ37598046-FA0697BB-BA82-43D2-A496-ADBB945FD509Q37600897-23C2CFF0-D1A5-4DC7-A6E6-09E7D8C10FE9Q37850402-C62B0ACC-728E-4DAA-A493-F61D16CE614AQ38203855-7BFFB25D-DAD0-4B8F-9D0D-8854A4BC3786Q38608049-93602CAE-1B28-44C0-9918-B7230EA4FF79Q38896839-F350A7F6-9557-46A0-8D9A-868D1171C403Q38935028-4FD970C6-F84A-47D2-82B2-AFA3FD69AAB2Q39434070-31F0DCB1-1EF9-4A58-AB0E-19956294C4DB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Babak Khoshnood
@ast
Babak Khoshnood
@en
Babak Khoshnood
@es
Babak Khoshnood
@nl
Babak Khoshnood
@sl
type
label
Babak Khoshnood
@ast
Babak Khoshnood
@en
Babak Khoshnood
@es
Babak Khoshnood
@nl
Babak Khoshnood
@sl
prefLabel
Babak Khoshnood
@ast
Babak Khoshnood
@en
Babak Khoshnood
@es
Babak Khoshnood
@nl
Babak Khoshnood
@sl
P106
P21
P31
P496
0000-0002-4031-4915